EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, AdaptHealth's enterprise value is $3,491 Mil.
AdaptHealth's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $3,200 Mil. Therefore, AdaptHealth's EV-to-Revenue for today is 1.09.
The historical rank and industry rank for AdaptHealth's EV-to-Revenue or its related term are showing as below:
AHCO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.71 Med: 1.78 Max: 4.49
Current: 1.09
During the past 7 years, the highest EV-to-Revenue of AdaptHealth was 4.49. The lowest was 0.71. And the median was 1.78.
AHCO's EV-to-Revenue is ranked better than 80.46% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 3.04
vs AHCO: 1.09
As of today (2024-04-26), AdaptHealth's stock price is $9.96.
AdaptHealth's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $23.80. Therefore, AdaptHealth's PS Ratio for today is 0.42.
AdaptHealth EV-to-Revenue Historical Data
The historical data trend for AdaptHealth's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AdaptHealth's EV-to-Revenue
For the Medical Devices subindustry, AdaptHealth's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AdaptHealth's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where AdaptHealth's EV-to-Revenue falls into.
AdaptHealth's current Enterprise Value is $3,491 Mil.
AdaptHealth's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,200 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth's share price for today is $9.96.
AdaptHealth's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of AdaptHealth's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AHCO has been successfully added to your 